[Status and prospects of the chemotherapy of viral infections].
D000447:Aldehydes / Q000627:therapeutic use; D000588:Amines / Q000627:therapeutic use; D000596:Amino Acids / Q000627:therapeutic use; D000963:Antimetabolites / Q000627:therapeutic use; D000998:Antiviral Agents / Q000494:pharmacology / Q000627:therapeutic use*; D004267:DNA Viruses / Q000187:drug effects; D006801:Humans; D007659:Ketones / Q000627:therapeutic use; D011687:Purines / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D012328:RNA Viruses / Q000187:drug effects; D013882:Thiosemicarbazones / Q000627:therapeutic use; D014777:Virus Diseases / Q000188:drug therapy*; D018406:Virus Physiological Phenomena; D014780:Viruses / Q000187:drug effects
D000447:Aldehydes; D000588:Amines; D000596:Amino Acids; D000963:Antimetabolites; D000998:Antiviral Agents; D007659:Ketones; D011687:Purines; D011743:Pyrimidines; D013882:Thiosemicarbazones
Sostoianie i perspektivy khimioterapii virusnykh infektsiĭ